[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Byrns et al., 2004 - Google Patents

The formation of substituted 1, N 6-etheno-2 '-deoxyadenosine and 1, N 2-etheno-2 '-deoxyguanosine adducts by cis-2-butene-1, 4-dial, a reactive metabolite of furan

Byrns et al., 2004

Document ID
7901816917658347508
Author
Byrns M
Vu C
Peterson L
Publication year
Publication venue
Chemical research in toxicology

External Links

Snippet

Furan is an environmental chemical that induces liver toxicity and tumor formation in rodents, leading to its classification as a probable human carcinogen. cis-2-Butene-1, 4-dial, the metabolite considered responsible for furan's toxicological effects, is mutagenic in the …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor

Similar Documents

Publication Publication Date Title
Byrns et al. The formation of substituted 1, N 6-etheno-2 ‘-deoxyadenosine and 1, N 2-etheno-2 ‘-deoxyguanosine adducts by cis-2-butene-1, 4-dial, a reactive metabolite of furan
Byrns et al. Characterization of nucleoside adducts of cis-2-butene-1, 4-dial, a reactive metabolite of furan
Zhang et al. Application of omics-and multi-omics-based techniques for natural product target discovery
Johnson et al. Applications of pulsed ultrafiltration‐mass spectrometry
Byrns et al. Detection of DNA adducts derived from the reactive metabolite of furan, cis-2-butene-1, 4-dial
Vartanian et al. Application of mass spectrometry profiling to establish brusatol as an inhibitor of global protein synthesis
Nelson et al. The essential medicinal chemistry of curcumin: miniperspective
Mally et al. Ochratoxin A: lack of formation of covalent DNA adducts
Gaspar et al. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors
Balbo et al. DNA adductomics
Aghajan et al. Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase
Gingipalli et al. Reaction of cis-and trans-2-butene-1, 4-dial with 2 ‘-deoxycytidine to form stable oxadiazabicyclooctaimine adducts
Zhang et al. Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo [a, l] pyrene by HPLC-MS/MS
Medeiros Exocyclic DNA adducts as biomarkers of lipid oxidation and predictors of disease. Challenges in developing sensitive and specific methods for clinical studies
Yuan et al. Characterization of a new insecticidal anthraquinone derivative from an endophyte of Acremonium vitellinum against Helicoverpa armigera
Yi et al. Synthesis and 32P-Postlabeling/High-Performance Liquid Chromatography Separation of Diastereomeric 1, N 2-(1, 3-Propano)-2 ‘-deoxyguanosine 3 ‘-Phosphate Adducts Formed from 4-Hydroxy-2-nonenal
Cho et al. Antitumor Agents. 164. Podophenazine, 2 ‘‘, 3 ‘‘-Dichloropodophenazine, Benzopodophenazine, and Their 4β-p-Nitroaniline Derivatives as Novel DNA Topoisomerase II Inhibitors
Cui et al. Total synthesis and target identification of the curcusone diterpenes
Woolner et al. Polyhalogenated indoles from the red alga rhodophyllis membranacea: The first isolation of bromo-chloro-iodo secondary metabolites
Li et al. Iakyricidins a–d, antiproliferative piericidin analogues bearing a carbonyl group or cyclic skeleton from Streptomyces iakyrus scsio ns104
Wauchope et al. Nuclear oxidation of a major peroxidation DNA adduct, M1dG, in the genome
Cavalieri et al. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo [a, l] pyrene (DB [a, l] P) or its metabolites and in rat mammary gland treated with DB [a, l] P
Meher et al. Development of 1, 3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer
Vaithiyalingam et al. Isolation and in silico study of curcumin from curcuma longa and its anti-diabetic activity
Zerangnasrabad et al. Design, synthesis, and structure–activity relationship study of O‐prenylated 3‐acetylcoumarins as potent inhibitors of soybean 15‐lipoxygenase